Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vivo

Currently viewing:

Administrative data

Endpoint:
in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
migrated information: read-across based on grouping of substances (category approach)
Adequacy of study:
key study
Study period:
11 Nov 1985 - 28 Jan 1986
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Acceptable, well documented study report which meets basic scientific priciples. Purity of test substance not given.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1986
Report date:
1986

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
Version / remarks:
adopted in 1981
Deviations:
yes
Remarks:
purity of test substance not given
GLP compliance:
yes
Type of assay:
micronucleus assay

Test material

Constituent 1
Reference substance name:
69275-01-0
Cas Number:
69275-01-0
IUPAC Name:
69275-01-0
Details on test material:
- Name of test material (as cited in study report): Di-(2-octyl-dodecyl)-sebacate
- Physical state: colourless, viscous liquid
- Analytical purity: no data

Test animals

Species:
mouse
Strain:
other: CFW 1
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Winkelmann
- Age at study initiation: 7 weeks
- Weight at study initiation: 18 - 31g
- Assigned to test groups randomly: yes
- Fasting period before study: 4 hours for 10000mg/kg bw group, 6-16 hours for other test groups
- Housing: one animal per cage in Makrolon Type I cages (male), 4 animals per cage in Makrolon Type II cages (female)
- Diet: Altromin 1324 diet, ad libitum
- Water: tap water, ad libitum

ENVIRONMENTAL CONDITIONS
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
- Vehicle(s)/solvent(s) used: oleum arachidis G 166, DAB8
- Amount of vehicle (if gavage or dermal): 10mL/kg bw
Details on exposure:
PREPARATION OF DOSING SOLUTIONS:
test substance was diluted using Oleum Arachidis G 166, DAB8 before application by gavage
Duration of treatment / exposure:
negative control, positive control, 1000 & 5000 mg/kg bw: 24 hours
10000 mg/kg bw: 24, 48, 72 hours
Frequency of treatment:
single treatment
Post exposure period:
24, 48 and 72 hours
Doses / concentrations
Remarks:
Doses / Concentrations:
1000, 5000, 10000 mg/kg bw
Basis:
actual ingested
No. of animals per sex per dose:
7
Control animals:
yes, concurrent vehicle
Positive control(s):
cyclophosphamide
- Route of administration: intraperitoneal
- Doses / concentrations: 10 mg/kg bw

Examinations

Tissues and cell types examined:
tissue: bone marrow from the femur
cell type: bone marrow cells
Details of tissue and slide preparation:
CRITERIA FOR DOSE SELECTION: Range finding study performed to find the maximum tolerated dose.

TREATMENT AND SAMPLING TIMES (in addition to information in specific fields): 24, 48 and 72 hours

DETAILS OF SLIDE PREPARATION: 3 slides per animal were fixed with methanol, stained for 10 minutes with Giemsa-solution (modified from Gollapudi and Kamra, 1979), rigorously washed with bidest water and air-dried over night.

METHOD OF ANALYSIS: 1 slide per animal was analyzed. The number of micronuclei in 1000 polychromatic erythrocytes was counted, additionally the ratio polychromatic erythrocytes to normocytes was determined.
Evaluation criteria:
Only regions on slides with a good cell distribution, intact cells and sufficient staining were evaluated. The ratio of polychromatic to normochromatic erythrocytes was determined by evaluating the number of bluish to red stained cells.
Statistics:
The statistic significance was calculated in comparison to controls using tables by Kastenbaum and Bowman (Mutation Research 2: 527-549; 1970).

Results and discussion

Test results
Sex:
male/female
Genotoxicity:
negative
Toxicity:
yes
Remarks:
5000, 10000 mg/kg bw dose groups: male and female animals showed slightly reduced activity and ruffled fur. Symptoms had disappeared 20 hours after application.
Vehicle controls validity:
valid
Negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
RESULTS OF RANGE-FINDING STUDY
- Dose range: 5000 - 10000 mg/kg bw
- Clinical signs of toxicity in test animals: none

Any other information on results incl. tables

Table 1: Results of the in vivo micronucleus assay in male animals.
 Total micronuclei per 1000 PCEs at sampling time Mean PCEs / 1000 NCEs at sampling time

Exp group

Number of animals Dose [mg/kg bw] 24 h 48 h 72 h 24 h 48 h 72 h
Vehicle control (oleum Arachidis, DAB8), 24 h 7 10 mL/kg bw 2 n.d. n.d. 0.73 n.d. n.d.
Positive control (cyclophosphamide), 24 h 7 10 8.71* n.d. n.d. 0.91 n.d. n.d.
Test substance 7 1000 n.d. n.d. n.d. n.d. n.d. n.d.
Test substance 7 5000 n.d. n.d. n.d. n.d. n.d. n.d.
Test substance 7 10000 0.86 1.57 1.71 0.94 1.11 1.07
*statistically significant (p>0.01), n.d. = not determined; in the highest dose group (10000 mg/kg bw) the group mean micronucleated cell count was comparable with the concurrent control values, therefore dosages of 1000 and 5000 mg/kg bw have not been evaluated.
Table 2: Results of the in vivo micronucleus assay in female animals.
 Total micronuclei per 1000 PCEs at sampling time  Mean PCEs / 1000 NCEs at sampling time

Exp group

Number of animals Dose [mg/kg bw] 24 h 48 h 72 h 24 h 48 h 72 h
Vehicle control (oleum Arachidis, DAB8), 24 h 7 10 mL/kg bw 2.14 n.d. n.d. 0.95 n.d. n.d.
Positive control (cyclophosphamide), 24 h 7 10 8.57* n.d. n.d. 0.88 n.d. n.d.
Test substance 7 1000 n.d. n.d. n.d. n.d. n.d. n.d.
Test substance 7 5000 n.d. n.d. n.d. n.d. n.d. n.d.
Test substance 7 10000 1.14 1.29 1.71 0.91 1.10 1.18
*statistically significant (p>0.01), n.d. = not determined; in the highest dose group (10000 mg/kg bw) the group mean micronucleated cell count was comparable with the concurrent control values, therefore dosages of 1000 and 5000 mg/kg bw have not been evaluated.

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information): negative